Overview

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BA058 is effective in building bone in postmenopausal women with osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Radius Health, Inc.
Treatments:
Abaloparatide
Parathyroid Hormone-Related Protein
Teriparatide